FDA study of intraocular lenses

Area of Science:

• Ophthalmology
• Medical Device Regulation

Background:

• Intraocular lens (IOL) implantation frequency has risen significantly in the U.S.
• Federal regulations and legal issues previously limited data availability.

Purpose of the Study:

• To assess the relative safety and effectiveness of intraocular lens implantation.
• To report findings from the initial two years of an FDA-monitored study.

Main Methods:

• Analysis of data from over 400,000 intraocular lens implantations.
• Evaluation of adverse reaction incidence and visual outcomes compared to control groups.

Main Results:

• A low average incidence of adverse reactions (1.94%) was observed.
• Visual results were comparable or superior to control cases, with 78% achieving 20/40 or better vision.

Conclusions:

• The initial two-year data suggest intraocular lens implantation is relatively safe and effective.
• Future data may differ due to changes in data base availability, excluding adjunct and approved lens information.